id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-5945-0003,FDA,FDA-2024-E-5945,Letter to U.S. Patent and Trademark Office,Other,Letter(s),2026-02-02T05:00:00Z,2026,2,2026-02-02T05:00:00Z,,2026-02-03T01:18:45Z,,0,0,09000064b918cabc
FDA-2024-E-5945-0002,FDA,FDA-2024-E-5945,Patent Extension Application from Covington & Burling LLP (on behalf of Genzyme Corp.),Other,Application,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T17:58:21Z,,0,0,0900006486894621
FDA-2024-E-5945-0001,FDA,FDA-2024-E-5945,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T17:54:20Z,,0,0,0900006486894620